These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 66320)

  • 21. Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence.
    Klein G; Vonka V
    J Natl Cancer Inst; 1974 Dec; 53(6):1645-6. PubMed ID: 4373574
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on Epstein-Barr virus-related antigens. I. Indirect single radial immunodiffusion as a useful method for detection and assay of soluble antigen.
    Matsuo T; Nishi S; Hirai H; Osato T
    Int J Cancer; 1976 Oct; 18(4):453-7. PubMed ID: 61945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of complement-fixing antigens in cells: Epstein-Barr virus-induced membrane and interior cell antigens.
    Hollinshead A; Lee O; Alford TC
    J Gen Virol; 1971 Dec; 13(3):441-7. PubMed ID: 4334299
    [No Abstract]   [Full Text] [Related]  

  • 26. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
    Shapiro IM; Andersson-Anvret M; Klein G
    Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Epstein-Barr virus-associated nuclear antigen and cell viability in human cell lines.
    Suzuki M; Hinuma Y
    Gan; 1975 Feb; 66(1):103-5. PubMed ID: 168112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of mitogens on the expression of Epstein-Barr virus antigens in human lymphoid cell lines.
    Tovey MG; Lenoir G; Begon-Lours J; Tapiero H; Rochette-Egly C
    J Immunol; 1979 Jul; 123(1):138-42. PubMed ID: 221589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
    Yanase S; Sugawara K
    Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers.
    Moar MH; Siegert W; Klein G
    Intervirology; 1978; 9(6):333-43. PubMed ID: 204604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells.
    Jondal M; Klein G; Oldstone MB; Bokish V; Yefenof E
    Scand J Immunol; 1976; 5(4):401-10. PubMed ID: 59946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS; Bertoni G; Takagi S; Sairenji T
    Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate).
    Moar MH; Siegert W; Klein G
    Intervirology; 1977; 8(4):226-39. PubMed ID: 194866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies on the induction of virus-associated nuclear antigen and early antigen by lymphocyte-transforming (B95-8) and nontransforming (P3HR-1) strains of Epstein-Barr virus.
    Menezes J; Patel P; Dussault H; Bourkas AE
    Intervirology; 1978; 9(2):86-94. PubMed ID: 201584
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
    Ito Y; Kishishita M; Yanase S
    Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability and dissociation of P3H4-1 Burkitt's lymphoma cell soluble complement-fixing antigen identified with human serum.
    Weliky N; Leaman DH; Kallman BJ
    Cancer Res; 1975 Jun; 35(6):1580-5. PubMed ID: 236823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
    Klein G; Falk L; Falk K
    Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Education of mouse lymphocytes against human lymphoblastoid cell lines: specific recognition of determinants independent of serologically defined HLA allotypes and Epstein-Barr virus-coded antigens.
    Carnaud C; Errasti P; van der Gaag R
    Eur J Immunol; 1979 Oct; 9(10):802-8. PubMed ID: 93053
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation of the Epstein-Barr virus nuclear antigen from chromatin preparations.
    Pikler GM; Pearson GR; Spelsberg TC
    IARC Sci Publ (1971); 1978; (24 Pt 1):243-7. PubMed ID: 221330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.